Evaluation of cephalosporin allergy: Survey of drug allergy experts
Increased uptake of direct oral challenge represents the initial impact of the 2022 DAPP. However, there is significant variation in testing practices of cephalosporin allergy even among drug allergy experts, reflecting a need for a firmer evidence base to guide consensus around testing for higher-risk reactions.
Authors
- Anna Brameli
- Cosby A. Stone (ORCID: https://orcid.org/0000-0002-1888-4188)
- Elizabeth Jane Phillips (ORCID: https://orcid.org/0000-0002-7623-3383)
Institutions
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1016/j.jacig.2024.100351
- Citations
- 1
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.45